Efficacy of low-dose methimazole in control of multiple relapses of Graves’ hyperthyroidism: a case report
Abstract Introduction Methimazole (MMI) is the treatment of choice for patients with Graves’ disease. The major drawback of this treatment is the relapse of hyperthyroidism in half of the patients after discontinuation of the recommended conventional 12–18 months of MMI treatment. TSH receptor antib...
Gardado en:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMC
2021-04-01
|
| Series: | Journal of Medical Case Reports |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1186/s13256-021-02788-4 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|